Elected Trades

REGN

REGENERON PHARMACEUTICALS, INC. · Wikipedia · Yahoo Finance chart ↗

Price

Last close
$973.36Last update Nov 3, 2026
12-month high
$975.49
12-month low
$591.52

Reported holders

Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.

NamePurchasedPrice that dayROI
Alan ArmstrongMar 27, 2026$737.71+31.94%
Julia Letlow Rank #10Feb 12, 2026$783.65+24.21%
Mark HarrisHeld as of Dec 31, 2025 (holdings report)Not availableNot available
Rob Bresnahan Rank #98May 15, 2025$584.99+66.39%

Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close. Holders listed from a holdings report alone have no purchase date, so no price or ROI.

All trades

Clear Filters
Public-equity transactions, newest transaction dates first
TickerPolitician NameTransaction TypeTrade DateFound Date
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Gilbert Cisneros, sale, May 15, 2026 Gilbert Cisneros Rank #22 Sale May 15, 2026 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock, Alan Armstrong, purchase, Mar 27, 2026 Alan Armstrong Purchase Mar 27, 2026 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Julia Letlow, purchase, Feb 12, 2026 Julia Letlow Rank #10 Purchase Feb 12, 2026 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Gilbert Cisneros, purchase, Nov 18, 2025 Gilbert Cisneros Rank #22 Purchase Nov 18, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Rob Bresnahan, purchase, May 15, 2025 Rob Bresnahan Rank #98 Purchase May 15, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Byron Donalds, sale, Apr 10, 2025 Byron Donalds Rank #60 Sale Apr 10, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Rob Bresnahan, sale, Apr 8, 2025 Rob Bresnahan Rank #98 Sale Apr 8, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Jefferson Shreve, sale, Apr 7, 2025 Jefferson Shreve Rank #123 Sale Apr 7, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Julie Johnson, sale, Apr 1, 2025 Julie Johnson Rank #43 Sale Apr 1, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Rob Bresnahan, sale, Feb 25, 2025 Rob Bresnahan Rank #98 Sale Feb 25, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Julie Johnson, sale, Feb 12, 2025 Julie Johnson Rank #43 Sale Feb 12, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Jan 24, 2025 Josh Gottheimer Rank #76 Sale Jan 24, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Julie Johnson, purchase, Jan 15, 2025 Julie Johnson Rank #43 Purchase Jan 15, 2025 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Nov 29, 2024 Josh Gottheimer Rank #76 Sale Nov 29, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Nov 19, 2024 Josh Gottheimer Rank #76 Sale Nov 19, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Jonathan Jackson, sale, Nov 13, 2024 Jonathan Jackson Rank #41 Sale Nov 13, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Jonathan Jackson, sale, Nov 1, 2024 Jonathan Jackson Rank #41 Sale Nov 1, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Oct 23, 2024 Josh Gottheimer Rank #76 Sale Oct 23, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Greg Landsman, sale, Oct 15, 2024 Greg Landsman Rank #73 Sale Oct 15, 2024 Sep 11, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Jul 1, 2024 Josh Gottheimer Rank #76 Sale Jul 1, 2024 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock, Thomas H Tuberville, sale, Apr 4, 2024 Thomas H Tuberville Rank #117 Sale Apr 4, 2024 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Josh Gottheimer, sale, Feb 8, 2024 Josh Gottheimer Rank #76 Sale Feb 8, 2024 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Jonathan Jackson, purchase, Jan 17, 2024 Jonathan Jackson Rank #41 Purchase Jan 17, 2024 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, sale, Nov 13, 2023 Josh Gottheimer Rank #76 Sale Nov 13, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, purchase, Aug 21, 2023 Josh Gottheimer Rank #76 Purchase Aug 21, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) [ST], Greg Landsman, purchase, Aug 11, 2023 Greg Landsman Rank #73 Purchase Aug 11, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, purchase, Jul 11, 2023 Josh Gottheimer Rank #76 Purchase Jul 11, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Jonathan Jackson, purchase, Jun 23, 2023 Jonathan Jackson Rank #41 Purchase Jun 23, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, sale, Jun 22, 2023 Josh Gottheimer Rank #76 Sale Jun 22, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock, Thomas H Tuberville, purchase, Apr 3, 2023 Thomas H Tuberville Rank #117 Purchase Apr 3, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, sale, Mar 6, 2023 Josh Gottheimer Rank #76 Sale Mar 6, 2023 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, purchase, Oct 19, 2022 Josh Gottheimer Rank #76 Purchase Oct 19, 2022 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, purchase, Sep 12, 2022 Josh Gottheimer Rank #76 Purchase Sep 12, 2022 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. (REGN) [ST], Josh Gottheimer, purchase, May 5, 2022 Josh Gottheimer Rank #76 Purchase May 5, 2022 Sep 12, 2026
REGN — Regeneron Pharmaceuticals, Inc. - Common Stock, Thomas H Tuberville, sale, Mar 30, 2022 Thomas H Tuberville Rank #117 Sale Mar 30, 2022 Sep 12, 2026